People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.
Sources
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină
Latest News
13:20
Automotive suppliers are losing more jobs than large manufacturers, and new investments are shifting towards electric vehicles.
13:17
Designer John Galliano will have a retrospective at the Metropolitan Museum of Art in New York, starting in May 2027. The exhibition will analyze his career and past controversies.
13:04
Three lions from a zoo in Tokyo have died, with heat shock suspected as the main cause.
12:54
A SpaceX rocket will collide with the Moon/ The impact will provide research opportunities on the lunar composition
12:50
Sameday has completed the full acquisition of the courier company Cargus
See more news